{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:15:57Z","timestamp":1772813757821,"version":"3.50.1"},"reference-count":36,"publisher":"American Physiological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiological Genomics"],"published-print":{"date-parts":[[2001,4,27]]},"abstract":"<jats:p>Oligonucleotide DNA microarrays were investigated for utility in measuring global expression profiles of drug metabolism genes. This study was performed to investigate the feasibility of using microarray technology to minimize the long, expensive process of testing drug candidates for safety in animals. In an evaluation of hybridization specificity, microarray technology from Affymetrix distinguished genes up to a threshold of \u223c90% DNA identity. Oligonucleotides representing human cytochrome P-450 gene CYP3A5 showed heterologous hybridization to CYP3A4 and CYP3A7 RNAs. These genes could be clearly distinguished by selecting a subset of oligonucleotides that hybridized selectively to CYP3A5. Further validation of the technology was performed by measuring gene expression profiles in livers of rats treated with vehicle, 3-methylcholanthrene (3MC), phenobarbital, dexamethasone, or clofibrate and by confirming data for six genes using quantitative RT-PCR. Responses of drug metabolism genes, including CYPs, epoxide hydrolases ( EHs), UDP-glucuronosyl transferases ( UGTs), glutathione sulfotransferases ( GSTs), sulfotransferases ( STs), drug transporter genes, and peroxisomal genes, to these well-studied compounds agreed well with, and extended, published observations. Additional gene regulatory responses were noted that characterize metabolic effects or stress responses to these compounds. Thus microarray technology can provide a facile overview of gene expression responses relevant to drug metabolism and toxicology.<\/jats:p>","DOI":"10.1152\/physiolgenomics.2001.5.4.161","type":"journal-article","created":{"date-parts":[[2017,12,23]],"date-time":"2017-12-23T22:41:01Z","timestamp":1514068861000},"page":"161-170","source":"Crossref","is-referenced-by-count":107,"title":["Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays"],"prefix":"10.1152","volume":"5","author":[{"given":"DAVID","family":"GERHOLD","sequence":"first","affiliation":[{"name":"Pharmacology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEIQING","family":"LU","sequence":"additional","affiliation":[{"name":"Pharmacology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JIAN","family":"XU","sequence":"additional","affiliation":[{"name":"Pharmacology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHRISTOPHER","family":"AUSTIN","sequence":"additional","affiliation":[{"name":"Pharmacology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. THOMAS","family":"CASKEY","sequence":"additional","affiliation":[{"name":"Pharmacology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"THOMAS","family":"RUSHMORE","sequence":"additional","affiliation":[{"name":"Drug Metabolism Department, Merck Research Laboratories, West Point, Pennsylvania 19486"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24","reference":[{"key":"R1","doi-asserted-by":"crossref","unstructured":"Alexander DL, Ganem LG, Fernandez-Salguero P, Gonzalez F, and Jefcoate CR.Aryl-hydrocarbon receptor is an inhibitory regulator of lipid synthesis and of commitment to adipogenesis.J Cell Sci111: 3311\u20133322, 1998.","DOI":"10.1242\/jcs.111.22.3311"},{"key":"R2","doi-asserted-by":"crossref","unstructured":"Aoyama T, Hardwick JP, Imaoka S, Funae Y, Gelboin HV, and Gonzalez FJ.Clofibrate-inducible rat hepatic P450s IVA1 and IVA3 catalyze the omega- and (omega-1)-hydroxylation of fatty acids and the omega-hydroxylation of prostaglandins E1 and F2 alpha.J Lipid Res31: 1477\u20131482, 1990.","DOI":"10.1016\/S0022-2275(20)42618-5"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80209-9"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.21.12208"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2571(97)00013-7"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1999.1011"},{"key":"R7","unstructured":"Correia MA.Rat and human liver cytochromes P450. In:Cytochrome P450s, Structure, Mechanism, and Biochemistry(2nd ed.), edited by Ortiz de Montellano PR. New York: Plenum, 1995, p. 610\u2013611."},{"key":"R8","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.26.15623"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.23.8242"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1038\/364555a0"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0004(99)01382-1"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60210-0"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1996.0414"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-4165(97)00157-8"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.18.10.5652"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1998.0880"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80900-9"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1296-1675"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.26.16125"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1038\/3282"},{"key":"R21","unstructured":"Metz G, Sim AK, McCraw AP, and Cleland ME.Effect of etofylline clofibrate on experimental thrombus formation and prostacyclin activation.Arzneimittelforschung36: 1363\u20131365, 1986."},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.1997.0491"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-180-42189"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1093\/jn\/129.11.1958"},{"key":"R25","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.10.3826"},{"key":"R26","doi-asserted-by":"crossref","unstructured":"Sakuma T, Ohtake M, Katsurayama Y, Jarukamjorn K, and Nemoto N.Induction of CYP1A2 by phenobarbital in the livers of aryl hydrocarbon-responsive and -nonresponsive mice.Drug Metab Dispos27: 379\u2013384, 1999.","DOI":"10.1016\/S0090-9556(24)14914-8"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1002\/bies.950180513"},{"key":"R28","unstructured":"Schiaffonati L and Tiberio L.Gene expression in liver after toxic injury: analysis of heat shock response and oxidative stress-inducible genes.Liver17: 183\u2013191, 1997."},{"key":"R29","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-3623(96)00246-7"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9228"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.19.2088"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.40.25713"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1006\/abio.1999.4022"},{"key":"R34","unstructured":"Whitlock JP and Denison MS.Induction of cytochrome P450 enzymes that metabolize xenobiotics. In:Cytochrome P450s, Structure, Mechanism, and Biochemistry(2nd ed.), edited by Ortiz de Montellano PR. New York: Plenum, 1995, p. 367."},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.19.291"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(99)00176-6"}],"container-title":["Physiological Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.physiology.org\/doi\/pdf\/10.1152\/physiolgenomics.2001.5.4.161","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T04:47:46Z","timestamp":1751172466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.physiology.org\/doi\/10.1152\/physiolgenomics.2001.5.4.161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,27]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4,27]]}},"alternative-id":["10.1152\/physiolgenomics.2001.5.4.161"],"URL":"https:\/\/doi.org\/10.1152\/physiolgenomics.2001.5.4.161","relation":{},"ISSN":["1094-8341","1531-2267"],"issn-type":[{"value":"1094-8341","type":"print"},{"value":"1531-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,27]]}}}